NNSA reaches milestone with cooperative agreements to accelerate domestic production of Mo99 

​

The U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) announced that it has entered into follow-on cooperative agreements with three commercial entities to establish a reliable domestic source of molybdenum-99 (Mo-99) that will be produced without the use of highly enriched uranium (HEU). These cooperative agreements fund the following efforts:

• SHINE Medical Technologies’ development of an accelerator with low enriched uranium (LEU) fission technology;

• NorthStar Medical Radioisotopes, LLC’s development of an accelerator technology; and

• General Atomics’ development of an LEU target fission technology.

NNSA’s support to these commercial entities is based on a 50/50 percent government/ commercial cost-share basis, up to a total of $25 million NNSA contribution to each project. These follow-on cooperative agreements mark an important milestone for the NNSA Mo-99 Program, as they complete the full $25 million NNSA contribution toward each commercial project.

To read more please visit: http://www.yournuclearnews.com/nnsa+reaches+milestone+with+cooperative+agreements+to+accelerate+domestic+production+of+mo99_139170.html

Source: NewsBase